Episodes: 167
Frequency: Weekly
Rating: 4.5/5.0
Estimated listeners: 100 - 1,000
Gender skew: Male
Listener location: USA
YouTube: 247 subscribers
Publicly listed emails
team@biotechhangout.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Daphne Zohar - Founder and chief executive officer of PureTech Health, focused on developing and commercializing biotechnology and healthcare innovations.
Josh Schimmer - Biotechnology equity research analyst and managing director at Evercore ISI, specializing in biotech companies, therapeutics, and industry developments.
Brad Loncar - Biotechnology investor and chief executive officer of Loncar Investments, known for investment strategies focused on biotech and healthcare companies.
Tim Opler - Investment banker and biotechnology industry commentator with expertise in healthcare companies, financing, and dealmaking.
Jake Becraft - Biotech Dealmaking, Ipos And Reverse Mergers, China Biotech, FDA Designations, Oncology Development, And The Pharmaceutical Market.
Episode 198 - October 2, 2026
October 02, 2026
On this week's episode, Graig Suvannavejh, Sam Fazeli, Eric Schmidt, and Brian Skorney open with a look at the public markets, noting the XBI is up 27% year-to-date but down about 9% since its August high. The co-hosts then touched on Oura's pulled IPO, seeing little read-through for the broader biotech space. In deals, Sanofi and Regeneron extended their antibody collaboration for $1 billion upfront and up to $7 billion in milestones, while AstraZeneca and Daiichi Sankyo struck deals...
Episode 197 - September 25, 2026
September 25, 2026
On this week's episode, Sam Fazeli, Yaron Werber, Brian Skorney, and Matt Gline open with the IPO market, noting record average raise sizes even as XBI softens. The group turns to policy, unpacking newly FOIA-disclosed details of Pfizer's MFN agreement, including a revenue-share provision tied to price increases abroad. The co-hosts call the equalization concept constructive but warn cash-strapped European governments may ration access rather than pay more. They also discuss FDA commi...
Episode 196 - September 18, 2026
September 25, 2026
On this week's episode, Josh Schimmer, Eric Schmidt, Paul Matteis, and guest Adam Feuerstein open with the OpenAI/Hugging Face AI agent controversy, debating whether calls for AI regulation reflect genuine safety concern or capital rotating out of biotech into AI. Turning to markets, the group describes a choppy September for biotech, driven more by rate jitters and a quiet M&A backdrop than any real shift in FDA or drug-pricing sentiment. In data news, Xenon Pharmaceuticals voluntari...
Biotech Hangout is hosted by Daphne Zohar and Josh Schimmer. Its publicly listed email is team@biotechhangout.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for Biotech Hangout: team@biotechhangout.com.
Podseeker estimates Biotech Hangout reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
Biotech Hangout typically books industry leaders. Typical guest background: Biotechnology or pharmaceutical executives, drug-development leaders, healthcare investors and analysts, or specialists with substantial expertise in clinical trials, regulation, financing, or biotech strategy. Common among recent guests: Led a biotechnology or pharmaceutical company; Advanced a drug-development or clinical-stage program; Built expertise in biotech investing, equity research, or dealmaking. Recent guests include Jake Becraft.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Biotechnology, Drug Development, Pharmaceuticals, Fda, and Biotech Investing. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
team@biotechhangout.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings